You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug-Induced Nephrotoxicity

Frank A. Krumlovsky, MD

Arch Dermatol. 1983;119(8):681-682.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The kidneys are remarkably susceptible to damage by drugs.1,2 Some of these agents, eg, aminoglycoside antibiotics, are well-known nephrotoxins and are used with appropriate caution. The nephrotoxic potential of many other widely used drugs, including newer agents, eg, the nonsteroidal anti-inflammatory drugs, as well as such older agents as furosemide, allopurinol, iodinated contrast media, cephalosporins, penicillins, sulfonamides, and tetracyclines, is less well recognized. This article is a brief review of the agents in these groups of drugs that appear to be of the greatest clinical importance.

PROSTAGLANDIN INHIBITORS

These compounds include the nonsteroidal antiinflammatory drugs, widely used in the treatment of a number of rheumatologic disorders. Aspirin and phenacetin also fall into this category. Most prostaglandins are renal vasodilators, and, consequently, agents that inhibit prostaglandin synthesis, eg, indomethacin, phenylbutazone, ibuprofen, fenoprofen calcium, naproxen, sulindac, tolmetin sodium, and zomepirac sodium, as well as aspirin and phenacetin, may decrease renal blood . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Medicine, Northwestern University Medical School, Chicago.


Footnotes

Accepted for publication Nov 2, 1982.

Reprint requests to Northwestern Memorial Hospital, Wesley Pavilion, Room 446, 250 E Superior St, Chicago, IL 60611 (Dr Krumlovsky).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.